Response of exercise-onset vasodilator kinetics to L-citrulline supplementation during different phases of the menstrual cycle.
- 2020-08
- RCT · n = 13
- Physiological reports 8(15)
- Joaquin U Gonzales
- Stephen M Fischer
- Arun Maharaj
- Heather Vellers
- Todd Anderson
- Adcharee Karnjanapiboonwong
- Seenivasan Subbiah
- J M Kellawan
- Arturo Figueroa
- PubMed: 32776464
- DOI: 10.14814/phy2.14536
- High evidence
- Adults
Analysis of variance showed no difference in the amplitude of ΔFVC between CIT and placebo (p = .45) ... Additionally, τΔFVC was not different (p = .35) between CIT and placebo in women tested during the follicular (6 ± 3 versus 5 ± 3 duty cycles) or luteal phase (9 ± 1 versus 8 ± 1 duty cycles)
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 6 g/day